Breakpoints
Society of Infectious Diseases Pharmacists
The SIDP Podcast
Top mentioned books
Here are the most frequently recommended books on the Breakpoints podcast:
#1 Mentioned in 1 episodes
Tabelecleucel for allogeneic haematopoietic stem-cell or solid organ transplant recipients with Epstein-Barr virus-positive post-transplant lymphoproliferative disease after failure of rituximab or rituximab and chemotherapy (ALLELE): a phase 3, multicentre, open-label trial
Mahadeo et al.
#2 Mentioned in 1 episodes
AVENIR: Azithromycin to Reduce Mortality — An Adaptive Cluster-Randomized Trial
O'Brien et al.
#3 Mentioned in 1 episodes
Application of OpenAI GPT-4 for the retrospective detection of catheter-associated urinary tract infections in a fictitious and curated patient data set
Perret et al.
#4 Mentioned in 1 episodes
PROPHY-VAP: Ceftriaxone to prevent early ventilator-associated pneumonia in patients with acute brain injury: a multicentre, randomised, double-blind, placebo-controlled, assessor-masked superiority trial
O'Brien et al.
#5 Mentioned in 1 episodes
AMIKINHAL: Inhaled Amikacin to Prevent Ventilator-Associated Pneumonia
O'Brien et al.
#6 Mentioned in 1 episodes
Assisting the infection preventionist: Use of artificial intelligence for health care–associated infection surveillance
Wiemken et al.
#7 Mentioned in 1 episodes
Bacteremia From a Presumed Urinary Source in Hospitalized Adults With Asymptomatic Bacteriuria
Advani et al.
#8 Mentioned in 1 episodes
Third-party virus-specific T cells for the treatment of double-stranded DNA viral reactivation and posttransplant lymphoproliferative disease after solid organ transplant
Khoury et al.
#9 Mentioned in 1 episodes
Oral versus intravenous empirical antibiotics in children and adolescents with uncomplicated bone and joint infections: a nationwide, randomised, controlled, non-inferiority trial in Denmark
Nielsen et al.
#10 Mentioned in 1 episodes
MSG-15: Super-Bioavailability Itraconazole Versus Conventional Itraconazole in the Treatment of Endemic Mycoses—A Multicenter, Open-Label, Randomized Comparative Trial
Spec et al.
#11 Mentioned in 1 episodes
Protect trial: Decolonization in Nursing Homes to Prevent Infection and Hospitalization
Miller et al.
#12 Mentioned in 1 episodes
Contact precautions for MRSA and VRE: where are we now? A survey of the Society for Healthcare Epidemiology of America Research Network
Martin et al.
#13 Mentioned in 1 episodes
Twice-Yearly Lenacapavir or Daily F/TAF for HIV Prevention in Cisgender Women
Bekker et al.
#14 Mentioned in 1 episodes
Short Oral Antibiotic Therapy for Pediatric Febrile Urinary Tract Infections: A Randomized Trial
Montini et al.
#15 Mentioned in 1 episodes
Early Versus Late Antipseudomonal β-Lactam Antibiotic Dose Adjustment in Critically Ill Sepsis Patients With Acute Kidney Injury: A Prospective Observational Cohort Study
Aldardeer et al.
#16 Mentioned in 1 episodes
Improving Short Course Treatment of Pediatric Infections: A Randomized Quality Improvement Trial
Vernacchio et al.
#17 Mentioned in 1 episodes
Effects of a multimodal intervention in primary care to reduce second line antibiotic prescriptions for urinary tract infections in women: parallel, cluster randomised, controlled trial
Schmiemann et al.
#18 Mentioned in 1 episodes
Evaluation of hospital-onset bacteraemia and fungaemia in the USA as a potential healthcare quality measure: a cross-sectional study
Leekha et al.
#19 Mentioned in 1 episodes
The Durability of Antibody Responses of Two Doses of High-Dose Relative to Two Doses of Standard-Dose Inactivated Influenza Vaccine in Pediatric Hematopoietic Cell Transplant Recipients: A Multi-Center Randomized Controlled Trial
Schuster et al.
#20 Mentioned in 1 episodes
Comparison of Two High-Dose Versus Two Standard-Dose Influenza Vaccines in Adult Allogeneic Hematopoietic Cell Transplant Recipients
Thomas et al.
